Price
No data yet.
Social Signal Score
Revenue
$0.00-100.00%Company Profile
- CEO
- Kim K. Thompson
- Sector
- Industrials
- Industry
- Manufacturing - Textiles
- Employees
- 37
- Beta
- 1.56
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -17.90
Financials
Revenue
$0.00-100.0%Net Income
$-909.5KEBITDA
$-696.3KFree Cash Flow
$-627.3KEPS (diluted)
$-0.00Shares Outstanding (diluted)
1.11B+45.6%Operating Expenses
$508.6KCash & Debt
$3.39MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-3.62M | $-0.00 |
| 2024 | $0.00 | $-3.40M | $-0.00 |
| 2023 | $0.00 | $-3.03M | $-0.00 |
| 2022 | $0.00 | $-3.84M | $-0.00 |
| 2021 | $0.00 | $-8.05M | $-0.01 |
| 2020 | $0.00 | $-5.36M | $-0.01 |
| 2019 | $0.00 | $-3.20M | $-0.00 |
| 2018 | $401.6K | $-1.17M | $-0.00 |
| 2017 | $97.3K | $-2.33M | $-0.00 |
| 2016 | $31.9K | $-3.07M | $-0.00 |
| 2015 | $0.00 | $-2.13M | $-0.00 |
| 2014 | $0.00 | $-1.87M | $-0.00 |
| 2013 | $0.00 | $-7.47M | $-0.01 |
| 2012 | $0.00 | $-1.20M | $-0.00 |
Valuation
KBLBhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·1d ago·Neutral
Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold ANN ARBOR, Mich., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its September/October production cycle is well underway, with all three production centers running.
View source ↗ - Newsglobenewswire.com·7d ago·Neutral
Kraig Labs Takes Biggest Step Yet and Ships First Commercial Spider Silk Order, as Performance Brand Set to Put Breakthrough Fiber to the Test DENVER, Sept. 29, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- Kraig Biocraft Laboratories (OTCQB: KBLB) reached a significant commercialization milestone, announcing the shipment of its first commercial order of recombinant spider silk yarn to a globally recognized performance sports brand.
View source ↗ - Newsglobenewswire.com·7d ago·Neutral
Kraig Biocraft Laboratories Ships its First Commercial Spider Silk Yarn Order for Performance Sports Brand Kraig Labs (OTCQB:KBLB) ships first commercial spider silk order to globally recognized performance sports brand, slated for development into a first-of-it
View source ↗ - Newsglobenewswire.com·22d ago·Neutral
As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers ANN ARBOR, Mich., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today highlighted the growing opportunity for advanced biomaterials in fashion as New York Fashion Week begins.
View source ↗ - Newsglobenewswire.com·33d ago·Negative
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality Kraig Labs (OTCQB:KBLB) featured in Tech Times examining the scientific gap between fictional biology and real-world advances in spider silk production.
View source ↗ - Newsglobenewswire.com·43d ago·Neutral
Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year Kraig Labs (OTCQB: KBLB) set another spider silk production record, over 30% more than its previous record levels, even during the difficult rainy season
View source ↗ - Newsglobenewswire.com·57d ago·Negative
Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare Kraig Labs (OTCQB: KBLB) CEO published a thought leadership scientific opinion editorial in Biocompare, serving the life sciences and biotech research comm
View source ↗
Insider trading
Open-market buys and sells by KBLB officers and directors.
- Bought
- —
- Sold
- $448k
0 trades
74 trades
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
- Thompson Kimberly Kraigsold
17 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in KBLB.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.